177 related articles for article (PubMed ID: 37436574)
21. p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients.
Lee J; An JN; Hwang JH; Lee H; Lee JP; Kim SG
PLoS One; 2019; 14(3):e0213981. PubMed ID: 30897126
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK
Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
[TBL] [Abstract][Full Text] [Related]
24. Arteriolar C4d in IgA Nephropathy: A Cohort Study.
Faria B; Canão P; Cai Q; Henriques C; Matos AC; Poppelaars F; Gaya da Costa M; Daha MR; Silva R; Pestana M; Seelen MA
Am J Kidney Dis; 2020 Nov; 76(5):669-678. PubMed ID: 32439421
[TBL] [Abstract][Full Text] [Related]
25. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
[TBL] [Abstract][Full Text] [Related]
26. Development and validation of a diagnostic nomogram to evaluate tubular atrophy/interstitial fibrosis of IgA nephropathy.
Gan Y; Cai Y; Li J; Wu J; Zhang R; Han Q; Li W; Yang Q
Int J Med Sci; 2024; 21(4):674-680. PubMed ID: 38464822
[No Abstract] [Full Text] [Related]
27. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
28. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
[TBL] [Abstract][Full Text] [Related]
29. Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.
Mizerska-Wasiak M; Małdyk J; Rybi-Szumińska A; Wasilewska A; Miklaszewska M; Pietrzyk J; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Pukajło-Marczyk A; Zwolińska D; Szczepańska M; Turczyn A; Roszkowska-Blaim M
Pediatr Nephrol; 2015 Jul; 30(7):1113-20. PubMed ID: 25549975
[TBL] [Abstract][Full Text] [Related]
30. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
31. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A;
Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
[TBL] [Abstract][Full Text] [Related]
32. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
Trimarchi H; Barratt J; Cattran DC; Cook HT; Coppo R; Haas M; Liu ZH; Roberts IS; Yuzawa Y; Zhang H; Feehally J; ;
Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
[TBL] [Abstract][Full Text] [Related]
33. Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis.
Sparding N; Genovese F; Rasmussen DGK; Karsdal MA; Neprasova M; Maixnerova D; Satrapova V; Frausova D; Hornum M; Bartonova L; Honsova E; Kollar M; Koprivova H; Hruskova Z; Tesar V
Nephrol Dial Transplant; 2022 May; 37(6):1099-1108. PubMed ID: 33914059
[TBL] [Abstract][Full Text] [Related]
34. Role of tubulointerstitial plasmin in the progression of IgA nephropathy.
Uchida T; Oda T; Takechi H; Matsubara H; Watanabe A; Yamamoto K; Oshima N; Sakurai Y; Kono T; Shimazaki H; Tamai S; Kumagai H
J Nephrol; 2016 Feb; 29(1):53-62. PubMed ID: 25971850
[TBL] [Abstract][Full Text] [Related]
35. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K
PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841
[TBL] [Abstract][Full Text] [Related]
36. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
Segarra-Medrano A; Carnicer-Caceres C; Valtierra-Carmeno N; Agraz-Pamplona I; Ramos-Terrades N; Jatem Escalante E; Ostos-Roldan E
Nefrologia; 2017; 37(5):531-538. PubMed ID: 28946966
[TBL] [Abstract][Full Text] [Related]
37. Coagulation parameters are associated with the prognosis of immunoglobulin a nephropathy: a retrospective study.
Xia M; Liu D; Peng L; Li Y; Liu H; Wu L; Chen G; Liu Y; Liu H
BMC Nephrol; 2020 Oct; 21(1):447. PubMed ID: 33109129
[TBL] [Abstract][Full Text] [Related]
38. Influences of renal anemia on the pathology of IgA nephropathy: a study based on propensity score matching.
Li F; Wei RB; Wang Y; Su TY; Li QP; Li P; Chen XM
Discov Med; 2020; 30(159):7-18. PubMed ID: 33357358
[TBL] [Abstract][Full Text] [Related]
39. [Effect of serum IgA/C3 and glomerular C3 staining on clinical prognosis in patients with IgA nephropathy].
Pei GQ; Qin AY; Wang SQ; Tan L; Tang Y; Qin W
Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2372-2377. PubMed ID: 32791814
[No Abstract] [Full Text] [Related]
40. Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images.
Testa F; Fontana F; Pollastri F; Chester J; Leonelli M; Giaroni F; Gualtieri F; Bolelli F; Mancini E; Nordio M; Sacco P; Ligabue G; Giovanella S; Ferri M; Alfano G; Gesualdo L; Cimino S; Donati G; Grana C; Magistroni R
Clin J Am Soc Nephrol; 2022 Sep; 17(9):1316-1324. PubMed ID: 35882505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
